Chemoinformaics analysis of Tetracosamethyl-cyclododecasiloxane
| Molecular Weight | 889.86 | nRot | 0 |
| Heavy Atom Molecular Weight | 817.284 | nRig | 24 |
| Exact Molecular Weight | 888.226 | nRing | 1 |
| Solubility: LogS | -9.397 | nHRing | 1 |
| Solubility: LogP | 9.994 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 120 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 48 | No. of Aromatic Carbocycles | 0 |
| nHetero | 24 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 12 | APOL | 164.073 |
| nHD | 0 | BPOL | 278.343 |
| QED | 0.217 |
| Synth | 4.728 |
| Natural Product Likeliness | 0.008 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.994 |
| HIA | 1 |
| CACO-2 | -6.695 |
| MDCK | 0.00025526 |
| BBB | 0 |
| PPB | 1.39325 |
| VDSS | 5.492 |
| FU | 1.66743 |
| CYP1A2-inh | 0.088 |
| CYP1A2-sub | 0.965 |
| CYP2c19-inh | 0.812 |
| CYP2c19-sub | 0.984 |
| CYP2c9-inh | 0.823 |
| CYP2c9-sub | 0.994 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.961 |
| CYP3a4-inh | 0.543 |
| CYP3a4-sub | 0.027 |
| CL | 2.355 |
| T12 | 0.029 |
| hERG | 0.35 |
| Ames | 0.011 |
| ROA | 0 |
| SkinSen | 0.964 |
| Carcinogencity | 0.007 |
| EI | 0.996 |
| Respiratory | 0.005 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.720878 |